Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01068158 · ClinicalTrials.gov registry record · Phase 3
A Study Comparing the Safety and Efficacy of 0.5% Ivermectin Cream to Placebo in Lice Infested Subjects
A Phase 3 study, sponsored by Topaz Pharmaceuticals.
- Completed
- Registry status
- Phase 3
- Development phase
- 371
- Enrollment target
NCT01068158 is a Phase 3 study that has completed, run by Topaz Pharmaceuticals. The registered enrollment target is 371 participants.
The verdict
NCT01068158, a Phase 3 study, has completed, sponsored by Topaz Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 371 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if 0.5% Ivermectin Cream is a safe and effective treatment for head lice infestations.
Interventions
- DRUG Placebo control
- DRUG 0.5% Ivermectin Cream
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 371 participants |
| Start Date | 2010-03 |
| Est. Completion | 2010-07 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01068158
The ClinicalTrials.gov registry entry for NCT01068158 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 371 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Topaz Pharmaceuticals, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo control is the first listed.
NCT01068158 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01068158 about?
NCT01068158 is a clinical study titled "A Study Comparing the Safety and Efficacy of 0.5% Ivermectin Cream to Placebo in Lice Infested Subjects". The purpose of this study is to determine if 0.5% Ivermectin Cream is a safe and effective treatment for head lice infestations.
What is the current status of trial NCT01068158?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 371 participants. The study started on 2010-03. Estimated completion is 2010-07.
What interventions are being tested in trial NCT01068158?
The interventions under investigation include: Placebo control (DRUG), 0.5% Ivermectin Cream (DRUG).
Who is sponsoring clinical trial NCT01068158?
This trial is sponsored by Topaz Pharmaceuticals, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.